Riskpilot← Back to searchSign inGet full accessSOS EYE AS
ASActiveOrg 928738140Ullern Allé 41, 0381 OsloMedical specialists activities · NACE 8622Est. 20224 employees
Revenue 2024
NOK 9M
+2% vs 2023
EBITDA margin
25.6%
-1% vs 2023
Equity ratio
1.3%
Financial strength
Net profit 2024
NOK 2,2M
-17% vs 2023
| Revenue | NOK 9M | +2% |
| EBITDA | NOK 2,3M | -1% |
| Net profit | NOK 2,2M | -17% |
| Total assets | NOK 3,9M | -34% |
| Equity | NOK 49K | -89% |
| Employees | 4 | — |
Legal name
SOS EYE AS
Org number
928738140
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
15. februar 2022
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av øyelegepraksis og andre relaterte helsetjenester, investering og deltakelse i andre selskaper og eiendom, samt alt annet som naturlig faller inn under dette.
Address
Ullern Allé 41, 0381 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 0 | 8 650 | 8 856 | 9 007 |
| Staff expenses | −0 | −2 270 | −2 207 | −2 477 |
| EBITDA | 0 | 2 026 | 2 332 | 2 307 |
| Depreciation & amort. | −0 | −9 | −28 | −53 |
| EBIT | 0 | 2 017 | 2 304 | 2 254 |
| Net financials | 0 | −512 | 839 | 466 |
| Profit before tax | 0 | 1 505 | 3 144 | 2 720 |
| Tax | −0 | 443 | 528 | 538 |
| Net profit | 0 | 1 062 | 2 616 | 2 182 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 30 | 7 598 | 5 872 | 3 880 |
| Equity | 19 | 1 081 | 467 | 49 |
| Long-term debt | 0 | 5 580 | 0 | 0 |
| Short-term debt | 11 | 937 | 5 405 | 3 831 |
| Total debt | 11 | 6 517 | 5 405 | 3 831 |
EBITDA margin
25.6%
This company
15.8%
Market median
+62% vs market
20212024
Equity ratio
1.3%
This company
38.2%
Market median
-97% vs market
20212024
Return on equity
4445.6%
This company
18.4%
Market median
+24061% vs market
20212024
Net profit margin
24.2%
This company
8.1%
Market median
+199% vs market
20212024
Asset turnover
2.32×
This company
1.12×
Market median
+107% vs market
20212024
Debt / equity
78.06×
This company
0.62×
Market median
-12490% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-12-15 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SO Chief Executive Officer | Chief Executive Officer | 2022 |
AN Deputy Member | Deputy Member | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sos Eye Holding As
SOS EYE AS Board members of SOS EYE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Svein Ove Semb | Chief Executive Officer | 0 companies |
| Adrian Nadau Semb | Deputy Member | 0 companies |
| Claudine Nadau Semb | Board of Directors | 0 companies |